Delivery Order SPE2DB22D1002-SPE2DB24FLFU7
Award Date
7/31/24
Potential Completion Date
8/1/24
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $6,846.79. The contract has an ultimate completion date of April 7, 2025 and is a Delivery Order under a Firm Fixed Price contract type. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,705.63, is for the delivery of the drug VERQUVO 10 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 28, 2024. The contract was awarded on October 25, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization,...
This is a $2,232.96 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of VERQUVO 5 MG TABLET UD 100S, a pharmaceutical product. The award has no set-aside designation and has an ultimate completion date of September 12, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., provides a wide range of prescription drugs, medical supplies, and equipment...
This federal contract award, valued at $2,854.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VERQUVO 5 MG TABLET 30S, a pharmaceutical product, and has an ultimate completion date of June 10, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The contract was not designated with a set-aside requirement, indicating open...
This is a $1,998.87 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) on June 6, 2025. The contract is for the delivery of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product, with a period of performance through June 9, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of the pharmaceutical product VERQUVO 5 MG TABLET 30S. The contract has a firm fixed price of $2,729.58 and an ultimate completion date of August 2, 2024. No set-aside designation was used for this award. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $4,319.32. The contract is for the delivery of VERQUVO 2.5 MG TABLET 30S, with a performance period running through April 14, 2025. This award does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $2,344.58 firm-fixed-price contract is for the supply of VERQUVO 5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of September 3, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,039.56, is for the delivery of 90 tablets of the medication VERQUVO 10 MG. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00, which provides a global pharmaceutical support vehicle to supply a wide range of medical products...
This federal contract award, valued at $1,354.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of VERQUVO 2.5 MG TABLET 30S, with an ultimate completion date of January 6, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...